4 completed, 1 unknown. 3 Not applicable, 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow 2'-fucosyllactose: new trials by email Literature Review of 2'-fucosyllactose trials Research Report on 2'-fucosyllactose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prebiotics in Reducing Inflammation and Clinical Endpoints in Ulcerative Colitis (PRInCE-UC) 2'-Fucosyllactose, Placebo - Ulcerative Colitis | Not applicable | Completed | Royal Berkshire NHS Foundation Trust | 38 | 2024-01-03 | 2026-02-12 |
| Effects of Human Milk Oligosaccharide Ingestion on Weight Loss and Markers of Health 2'-Fucosyllactose, Maltodextrin - Weight Loss | Not applicable | Completed | Advanced Protein Technologies Corporation | 60 | 2023-05-04 | 2024-08-14 |
| The Effect of Human Milk Oligosaccharides in Children With Type 1 Diabetes Mellitus 2-fucosyllactose - Diabetes Mellitus, Type1diabetes | Not applicable | Unknown | Ege University | 111 | 2022-05-28 | 2024-02-23 |
| Oral Supplementation of 2'-Fucosyllactose in Allogeneic Bone Marrow Transplant Recipients 2'-fucosyllactose - Hematopoietic Stem Cell Transplant | Phase 1 / Phase 2 | Completed | Children's Hospital Medical Center, Cincinnati | 70 | 2020-08-26 | 2026-09-02 |
| Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy 2'-Fucosyllactose, Placebo - Inflammatory Bowel Diseases, Crohn Disease | Phase 1 / Phase 2 | Completed | Children's Hospital Medical Center, Cincinnati | 128 | 2019-09-20 | 2026-08-06 |
Colitis, Ulcerative (2) · Crohn Disease (1) · Diabetes Mellitus (1) · Inflammation (1) · Inflammatory Bowel Diseases (1) · Weight Loss (1)
Children's Hospital Medical Center, Cincinnati (2) · Advanced Protein Technologies Corporation (1) · Ege University (1) · Royal Berkshire NHS Foundation Trust (1)
United States (3) · Turkey (Türkiye) (1) · United Kingdom (1)
Glenn Gibson, PhD (1) · Pooja Khandelwal, MD (1) · Richard B Kreider, Professor (1)
PMID 10865709, PMID 1645211, PMID 19935820, PMID 23851406, PMID 25328834, PMID 27719686, PMID 27851789, PMID 28670546, PMID 29280547, PMID 39408354, PMID 42622257, PMID 42635599, PMID 8667568